NCT01645800View on ClinicalTrials.gov

Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study

PHASE4CompletedINTERVENTIONAL

Enrollment

408

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

March 31, 2015

Conditions

COPD

Interventions

DRUG

Lysozyme hydrochloride

LYL 90mg capsule: Three times daily for 52 weeks.

DRUG

Placebo

Matching Placebo capsule: Three times daily for 52 weeks.

Trial Locations (25)

Unknown

Nishio

Noda

Fukuoka

Kasuga

Kyoto-gun

Yanagawa

Mabashi

Takasaki

Kitahiroshima

Sapporo

Himeji

Takamatsu

Yokohama

Yokosuka

Nagaoka

Ōita

Okayama

Osaka

Suita

Chuo-ku

Edogawa-ku

Higashikurume

Koto-ku

Setagaya-ku

Yamagata

All Listed Sponsors

lead

Eisai Co., Ltd.

INDUSTRY

NCT01645800 - Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study | Biotech Hunter | Biotech Hunter